COMMUNIQUÉS West-GlobeNewswire

BriaCell Therapeutics Announces Closing of $13.8 million Public Offering
28/04/2025
PHILADELPHIA and VANCOUVER, British Columbia, April 28, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that [...]
LifeMD to Report First Quarter 2025 Financial Results on May 6
28/04/2025
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD) , a leading provider of virtual primary care services, announces that it will report financial results for the three months ended March 31, 2025 [...]
Sutro Biopharma to Highlight its Next-Generation Exatecan and Dual-Payload ADC Programs in Presentations at AACR 2025
28/04/2025
- Preclinical findings show STRO-004's promising anti-tumor activity and favorable safety profile - SOUTH SAN FRANCISCO, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: [...]
Foghorn Therapeutics Presents New Preclinical Data on Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Programs and Provides Pipeline Update
28/04/2025
- FHD-909 (LY4050784) advancing in Phase 1 trial in SMARCA4 (BRG1) mutated cancers, with non-small cell lung cancer (NSCLC) as the primary target population - Preclinical synergistic anti-tumor activity of FHD-909 in [...]
CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinical and Corporate Updates
28/04/2025
SINGAPORE, April 28, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary [...]
Tempest Presents New Amezalpat MOA Data Reinforcing Its Potential as Novel Cancer Treatment at the 2025 AACR Annual Meeting
28/04/2025
BRISBANE, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class i targeted and immune-mediated therapeutics to fight [...]
Kane Biotech Announces Fourth Quarter and Full Year 2024 Financial Results, Narrows Strategic Focus and Makes Leadership Change
28/04/2025
WINNIPEG, Manitoba, April 28, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) today announced its fourth quarter and full year 2024 financial results. Fourth [...]
Bicara Therapeutics Highlights Broad Potential of Ficerafusp Alfa at AACR Annual Meeting 2025
28/04/2025
BOSTON, April 28, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, [...]
Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer
28/04/2025
CAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics , Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and [...]
Solésence To Report First Quarter 2025 Financial Results and Host a Conference Call
28/04/2025
ROMEOVILLE, Ill., April 28, 2025 (GLOBE NEWSWIRE) -- Romeoville, Ill., April 28, 2025 – Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, [...]
Nurix Therapeutics Presents Data at the AACR 2025 Annual Meeting Highlighting the Transformative Potential of Its Proprietary DEL-AI Platform Leveraging Machine Learning to Speed the Discovery of Novel Drugs
28/04/2025
Nurix’s DEL-AI platform uses a first-in-class DEL Foundation Model trained on the Company’s proprietary DNA encoded library data Nurix’s DEL Foundation Model can accurately predict novel binders to therapeutically [...]
CytomX Therapeutics Presents Preclinical Data for mRNA Encoded Masked IL-12 Molecule in Collaboration with Moderna at AACR Annual Meeting
28/04/2025
Novel engineering approach to developing an mRNA-encoded masked IL-12 therapeutic demonstrates potent anti-tumor activity with significantly enhanced tolerability SOUTH SAN FRANCISCO, Calif., April 28, 2025 (GLOBE [...]
Cronos Group Inc. to Hold Virtual 2025 Annual Meeting of Shareholders
28/04/2025
TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 Annual Meeting of Shareholders on Friday, June 20, 2025, at 11:00 a.m. ET. Cronos [...]
Frontier Medicines Unveils New Preclinical Data for FMC-220, a First-in-Class Covalent p53 Y220C Activator, at AACR 2025
28/04/2025
Sustained reactivation of mutant p53 drives durable anti-tumor activity across models, including KRAS co-mutant tumors FMC-220 selectively stabilizes p53 Y220C at lower doses, overcoming key limitations of non-covalent [...]
Supra Keto ACV Gummies: Best Gummies for Weight Loss 2025 - (Keto BHB + Keto Plus)
28/04/2025
New York, April 28, 2025 (GLOBE NEWSWIRE) -- Within the weight loss supplement industry, Supra Keto BHB + ACV Gummies are revolutionary, employing two of the best fat-burning compounds: Beta-Hydroxybutyrate (BHB) and [...]
Best Testosterone Boosters for Muscle Gain: Top Rated Testosterone Pills for Bodybuilding & Muscle Growth From TestoPrime
28/04/2025
Boost muscle gain, crush erectile dysfunction, and reclaim peak vitality naturally with top natural testosterone boosters like TestoPrime, powered by D-Aspartic Acid, Fenugreek, KSM-66 Ashwagandha, and Panax Ginseng. [...]
Sugar Defender Reviews [Blood Sugar Control Supplement 2025] User Complaints, Ingredients and Possible Side Effects?
28/04/2025
Sugar Defender's Secret Formula Finally Revealed – How It Supports Healthy Blood Sugar Naturally Albany, New York, April 28, 2025 (GLOBE NEWSWIRE) -- Sugar Defender's Secret Formula Finally Revealed – Know How It [...]
Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025
28/04/2025
90% of patients achieved high grade disease-free status at any time point with NDV-01, demonstrating strong proof-of-concept for sustained-release “GEM/DOCE” formulation* NDV-01 showed promising clinical activity in BCG [...]
SARMs Cardarine GW 50156: Cardarine For Sale, Cardarine Cycle, Cardarine Benefits, Cardarine Dosage, Cardarine Before and After, Cardarine Effects, Cardarine Side Effects, Buy, (C-Dine By CrazyBulk)
28/04/2025
New York City, April 28, 2025 (GLOBE NEWSWIRE) -- “C-DINE 501516 is an all natural, safe, and legal CARDARINE GW501516 alternative that delivers natural ingredients to help fire-up your metabolism and transition your [...]

Pages